Clinical Trial Update: Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 trial at Vanderbilt-Ingram Cancer Center is evaluating split-course adaptive radiation therapy with pembrolizumab, with or without chemotherap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | Phase 1, Phase 2 | Status: RECRUITING